Literature DB >> 25841268

[Cleft lip, alveolar and palate sequelae. Proposal of new alveolar score by the Alveolar Cleft Score (ACS) classification].

C Molé1, E Simon2.   

Abstract

INTRODUCTION: The management of cleft lip, alveolar and palate sequelae remains problematic today. To optimize it, we tried to establish a new clinical index for diagnostic and prognostic purposes. TECHNICAL NOTE: Seven tissue indicators, that we consider to be important in the management of alveolar sequelae, are listed by assigning them individual scores. The final score, obtained by adding together the individual scores, can take a low, high or maximum value. DISCUSSION: We propose a new classification (ACS: Alveolar Cleft Score) that guides the therapeutic team to a prognosis approach, in terms of the recommended surgical and prosthetic reconstruction, the type of medical care required, and the preventive and supportive therapy to establish. Current studies are often only based on a standard radiological evaluation of the alveolar bone height at the cleft site. However, the gingival, the osseous and the cellular areas bordering the alveolar cleft sequelae induce many clinical parameters, which should be reflected in the morphological diagnosis, to better direct the surgical indications and the future prosthetic requirements, and to best maintain successful long term aesthetic and functional results.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Classification; Cleft palate; Fentes palatines; Mouth rehabilitation; Oral surgical procedures; Procédures en chirurgie orale; Réhabilitation orale

Mesh:

Year:  2015        PMID: 25841268     DOI: 10.1016/j.revsto.2015.02.004

Source DB:  PubMed          Journal:  Rev Stomatol Chir Maxillofac Chir Orale        ISSN: 2213-6533


  1 in total

1.  Impact of a new combined preoperative cleft assessment on dental implant success in patients with cleft and palate: a retrospective study.

Authors:  Charles Savoldelli; Sonanda Bailleux; Emmanuel Chamorey; Clair Vandersteen; Barbara Lerhe; Franck Afota
Journal:  BMC Oral Health       Date:  2022-03-15       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.